Previous studies have demonstrated that high KDM1A expression is related to worse prognoses in various types of solid tumors, such as nonsmall cell lung cancer, colorectal cancer, neuroblastoma, prostate cancer and breast cancer [15,16,17,18,19]. This evidence concerns the gene KDM1A and breast cancer.